HEADER HYDROLASE/INHIBITOR 03-FEB-03 1OC0 TITLE PLASMINOGEN ACTIVATOR INHIBITOR-1 COMPLEX WITH SOMATOMEDIN B DOMAIN OF TITLE 2 VITRONECTIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: PLASMINOGEN ACTIVATOR INHIBITOR-1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ENDOTHELIAL PLASMINOGEN ACTIVATOR INHIBITOR, PAI-1, PAI; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: VITRONECTIN; COMPND 9 CHAIN: B; COMPND 10 FRAGMENT: SOMATOMEDIN B, RESIDUES 20-70; COMPND 11 SYNONYM: SERUM SPREADING FACTOR, S-PROTEIN, S75; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 TISSUE: BLOOD; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PET-11C; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 16 EXPRESSION_SYSTEM_STRAIN: AD494(DE3); SOURCE 17 EXPRESSION_SYSTEM_VECTOR: PGEX-4T2; SOURCE 18 OTHER_DETAILS: OBTAINED BY CNBR CLEAVAGE OF FUSION PROTEIN KEYWDS HYDROLASE-INHIBITOR COMPLEX, SERINE PROTEASE INHIBITOR-COMPLEX, KEYWDS 2 SERPIN, PROTEINASE INHIBITOR, FIBRINOLYSIS, CELL MIGRATION, KEYWDS 3 PLASMINOGEN ACTIVATION, HEPARIN-BINDING, CELL ADHESION EXPDTA X-RAY DIFFRACTION AUTHOR R.J.READ,A.ZHOU,J.A.HUNTINGTON,N.S.PANNU,R.W.CARRELL REVDAT 4 13-DEC-23 1OC0 1 REMARK REVDAT 3 24-FEB-09 1OC0 1 VERSN REVDAT 2 04-JUL-03 1OC0 1 JRNL REVDAT 1 19-JUN-03 1OC0 0 JRNL AUTH A.ZHOU,J.A.HUNTINGTON,N.S.PANNU,R.W.CARRELL,R.J.READ JRNL TITL HOW VITRONECTIN BINDS PAI-1 TO MODULATE FIBRINOLYSIS AND JRNL TITL 2 CELL MIGRATION JRNL REF NAT.STRUCT.BIOL. V. 10 541 2003 JRNL REFN ISSN 1072-8368 JRNL PMID 12808446 JRNL DOI 10.1038/NSB943 REMARK 2 REMARK 2 RESOLUTION. 2.28 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.28 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 20251 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.198 REMARK 3 R VALUE (WORKING SET) : 0.196 REMARK 3 FREE R VALUE : 0.252 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 989 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3187 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 137 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 45.81 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.20 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.01000 REMARK 3 B22 (A**2) : -0.76000 REMARK 3 B33 (A**2) : -0.25000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.339 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.242 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.170 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 6.866 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: TLS GROUPS USED FOR PAI-1 AND REMARK 3 SOMATOMEDIN B REMARK 4 REMARK 4 1OC0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 03-FEB-03. REMARK 100 THE DEPOSITION ID IS D_1290012062. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-APR-02 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.40 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0332 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL SI REMARK 200 OPTICS : FOCUSING MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : APS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20251 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.280 REMARK 200 RESOLUTION RANGE LOW (A) : 45.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 12.20 REMARK 200 R MERGE (I) : 0.11200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.28 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.37 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.00 REMARK 200 R MERGE FOR SHELL (I) : 0.73300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: BEAST REMARK 200 STARTING MODEL: PDB ENTRY 1B3K REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10MM NAOAC, 50MM NACL, 2-9% REMARK 280 PEG12000,25% PEG400, 50MM HEPES, PH 7.4, PH 7.40 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 23.75050 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 50.08150 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 45.04350 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 50.08150 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 23.75050 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 45.04350 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED MUTATION ASN 173 HIS, LYS 177 THR, GLN 342 LEU REMARK 400 AND MET 377 ILE IN CHAIN A. REMARK 400 REMARK 400 MOL_ID 1: INHIBITOR FOR TISSUE PLASMINOGEN ACTIVATOR (TPA), REMARK 400 PROTEIN C AND UROKINASE. RAPID INTERACTION WITH TPA COULD REMARK 400 ACT AS A CONTROL POINT IN THE REGULATION OF FIBRINOLYSIS. REMARK 400 HIGH CONCENTRATIONS IMPLICATED IN HUMAN THROMBOEMBOLIC REMARK 400 DISEASE. REMARK 400 REMARK 400 MOL_ID 2: SOMATOMEDIN B IS A GROWTH HORMONE-DEPENDENT SERUM REMARK 400 FACTOR THAT DISPLAYS PROTEASE-INHIBITING ACTIVITY. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 VAL A 1 REMARK 465 HIS A 2 REMARK 465 HIS A 3 REMARK 465 PRO A 4 REMARK 465 PRO A 5 REMARK 465 SER A 338 REMARK 465 THR A 339 REMARK 465 ALA A 340 REMARK 465 VAL A 341 REMARK 465 ILE A 342 REMARK 465 VAL A 343 REMARK 465 SER A 344 REMARK 465 ALA A 345 REMARK 465 ARG A 346 REMARK 465 MET A 347 REMARK 465 ASP B 1 REMARK 465 GLN B 2 REMARK 465 LYS B 40 REMARK 465 PRO B 41 REMARK 465 GLN B 42 REMARK 465 VAL B 43 REMARK 465 THR B 44 REMARK 465 ARG B 45 REMARK 465 GLY B 46 REMARK 465 ASP B 47 REMARK 465 VAL B 48 REMARK 465 PHE B 49 REMARK 465 THR B 50 REMARK 465 MET B 51 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O SER A 149 O HOH A 2050 2.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 29 CB - CG - OD2 ANGL. DEV. = 5.8 DEGREES REMARK 500 ASP A 125 CB - CG - OD2 ANGL. DEV. = 5.8 DEGREES REMARK 500 ASP A 193 CB - CG - OD2 ANGL. DEV. = 6.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 28 -130.61 66.02 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1A7C RELATED DB: PDB REMARK 900 HUMAN PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 IN COMPLEX WITH A REMARK 900 PENTAPEPTIDE REMARK 900 RELATED ID: 1B3K RELATED DB: PDB REMARK 900 PLASMINOGEN ACTIVATOR INHIBITOR-1 REMARK 900 RELATED ID: 1C5G RELATED DB: PDB REMARK 900 PLASMINOGEN ACTIVATOR INHIBITOR-1 REMARK 900 RELATED ID: 1DB2 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF NATIVE PLASMINOGEN ACTIVATOR INHIBITOR- 1 REMARK 900 RELATED ID: 1DVM RELATED DB: PDB REMARK 900 ACTIVE FORM OF HUMAN PAI-1 REMARK 900 RELATED ID: 1DVN RELATED DB: PDB REMARK 900 LATENT FORM OF PLASMINOGEN ACTIVATOR INHIBITOR -1 (PAI-1) REMARK 900 RELATED ID: 1LJ5 RELATED DB: PDB REMARK 900 1.8A RESOLUTION STRUCTURE OF LATENT PLASMINOGEN ACTIVATORINHIBITOR- REMARK 900 1(PAI-1) REMARK 900 RELATED ID: 9PAI RELATED DB: PDB REMARK 900 CLEAVED SUBSTRATE VARIANT OF PLASMINOGEN ACTIVATOR INHIBITOR-1 DBREF 1OC0 A 1 379 UNP P05121 PAI1_HUMAN 24 402 DBREF 1OC0 B 1 51 UNP P04004 VTNC_HUMAN 20 70 SEQADV 1OC0 HIS A 150 UNP P05121 ASN 173 ENGINEERED MUTATION SEQADV 1OC0 THR A 154 UNP P05121 LYS 177 ENGINEERED MUTATION SEQADV 1OC0 LEU A 319 UNP P05121 GLN 342 ENGINEERED MUTATION SEQADV 1OC0 ILE A 354 UNP P05121 MET 377 ENGINEERED MUTATION SEQRES 1 A 379 VAL HIS HIS PRO PRO SER TYR VAL ALA HIS LEU ALA SER SEQRES 2 A 379 ASP PHE GLY VAL ARG VAL PHE GLN GLN VAL ALA GLN ALA SEQRES 3 A 379 SER LYS ASP ARG ASN VAL VAL PHE SER PRO TYR GLY VAL SEQRES 4 A 379 ALA SER VAL LEU ALA MET LEU GLN LEU THR THR GLY GLY SEQRES 5 A 379 GLU THR GLN GLN GLN ILE GLN ALA ALA MET GLY PHE LYS SEQRES 6 A 379 ILE ASP ASP LYS GLY MET ALA PRO ALA LEU ARG HIS LEU SEQRES 7 A 379 TYR LYS GLU LEU MET GLY PRO TRP ASN LYS ASP GLU ILE SEQRES 8 A 379 SER THR THR ASP ALA ILE PHE VAL GLN ARG ASP LEU LYS SEQRES 9 A 379 LEU VAL GLN GLY PHE MET PRO HIS PHE PHE ARG LEU PHE SEQRES 10 A 379 ARG SER THR VAL LYS GLN VAL ASP PHE SER GLU VAL GLU SEQRES 11 A 379 ARG ALA ARG PHE ILE ILE ASN ASP TRP VAL LYS THR HIS SEQRES 12 A 379 THR LYS GLY MET ILE SER HIS LEU LEU GLY THR GLY ALA SEQRES 13 A 379 VAL ASP GLN LEU THR ARG LEU VAL LEU VAL ASN ALA LEU SEQRES 14 A 379 TYR PHE ASN GLY GLN TRP LYS THR PRO PHE PRO ASP SER SEQRES 15 A 379 SER THR HIS ARG ARG LEU PHE HIS LYS SER ASP GLY SER SEQRES 16 A 379 THR VAL SER VAL PRO MET MET ALA GLN THR ASN LYS PHE SEQRES 17 A 379 ASN TYR THR GLU PHE THR THR PRO ASP GLY HIS TYR TYR SEQRES 18 A 379 ASP ILE LEU GLU LEU PRO TYR HIS GLY ASP THR LEU SER SEQRES 19 A 379 MET PHE ILE ALA ALA PRO TYR GLU LYS GLU VAL PRO LEU SEQRES 20 A 379 SER ALA LEU THR ASN ILE LEU SER ALA GLN LEU ILE SER SEQRES 21 A 379 HIS TRP LYS GLY ASN MET THR ARG LEU PRO ARG LEU LEU SEQRES 22 A 379 VAL LEU PRO LYS PHE SER LEU GLU THR GLU VAL ASP LEU SEQRES 23 A 379 ARG LYS PRO LEU GLU ASN LEU GLY MET THR ASP MET PHE SEQRES 24 A 379 ARG GLN PHE GLN ALA ASP PHE THR SER LEU SER ASP GLN SEQRES 25 A 379 GLU PRO LEU HIS VAL ALA LEU ALA LEU GLN LYS VAL LYS SEQRES 26 A 379 ILE GLU VAL ASN GLU SER GLY THR VAL ALA SER SER SER SEQRES 27 A 379 THR ALA VAL ILE VAL SER ALA ARG MET ALA PRO GLU GLU SEQRES 28 A 379 ILE ILE ILE ASP ARG PRO PHE LEU PHE VAL VAL ARG HIS SEQRES 29 A 379 ASN PRO THR GLY THR VAL LEU PHE MET GLY GLN VAL MET SEQRES 30 A 379 GLU PRO SEQRES 1 B 51 ASP GLN GLU SER CYS LYS GLY ARG CYS THR GLU GLY PHE SEQRES 2 B 51 ASN VAL ASP LYS LYS CYS GLN CYS ASP GLU LEU CYS SER SEQRES 3 B 51 TYR TYR GLN SER CYS CYS THR ASP TYR THR ALA GLU CYS SEQRES 4 B 51 LYS PRO GLN VAL THR ARG GLY ASP VAL PHE THR MET FORMUL 3 HOH *137(H2 O) HELIX 1 1 SER A 6 ALA A 26 1 21 HELIX 2 2 SER A 35 THR A 50 1 16 HELIX 3 3 GLY A 51 GLY A 63 1 13 HELIX 4 4 GLY A 70 MET A 83 1 14 HELIX 5 5 GLY A 108 ARG A 118 1 11 HELIX 6 6 GLU A 128 HIS A 143 1 16 HELIX 7 7 PRO A 180 THR A 184 5 5 HELIX 8 8 HIS A 229 ASP A 231 5 3 HELIX 9 9 LEU A 247 ASN A 252 1 6 HELIX 10 10 SER A 255 HIS A 261 1 7 HELIX 11 11 LEU A 286 LEU A 293 1 8 HELIX 12 12 THR A 296 ARG A 300 5 5 HELIX 13 13 LEU B 24 GLN B 29 5 6 HELIX 14 14 ASP B 34 CYS B 39 1 6 SHEET 1 AA 6 VAL A 32 PHE A 34 0 SHEET 2 AA 6 VAL A 370 VAL A 376 -1 O MET A 373 N PHE A 34 SHEET 3 AA 6 PHE A 358 HIS A 364 -1 O PHE A 358 N VAL A 376 SHEET 4 AA 6 LEU A 233 PRO A 240 -1 O SER A 234 N ARG A 363 SHEET 5 AA 6 TYR A 220 PRO A 227 -1 O ASP A 222 N ALA A 239 SHEET 6 AA 6 TYR A 210 THR A 214 -1 O THR A 211 N ILE A 223 SHEET 1 AB 5 LYS A 122 VAL A 124 0 SHEET 2 AB 5 ILE A 91 GLN A 100 1 O ILE A 97 N LYS A 122 SHEET 3 AB 5 LEU A 163 ASN A 172 -1 O VAL A 164 N PHE A 98 SHEET 4 AB 5 LEU A 319 VAL A 328 1 O LEU A 319 N LEU A 165 SHEET 5 AB 5 PHE A 278 ASP A 285 -1 O PHE A 278 N VAL A 328 SHEET 1 AC 4 HIS A 185 HIS A 190 0 SHEET 2 AC 4 THR A 196 PHE A 208 -1 O VAL A 197 N PHE A 189 SHEET 3 AC 4 LEU A 269 PRO A 276 -1 O LEU A 269 N PHE A 208 SHEET 4 AC 4 GLU A 351 ILE A 353 1 O ILE A 352 N VAL A 274 SSBOND 1 CYS B 5 CYS B 21 1555 1555 2.04 SSBOND 2 CYS B 9 CYS B 39 1555 1555 2.03 SSBOND 3 CYS B 19 CYS B 32 1555 1555 2.03 SSBOND 4 CYS B 25 CYS B 31 1555 1555 2.06 CRYST1 47.501 90.087 100.163 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021052 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011100 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009984 0.00000